HIV
Trial Demonstrates Safety and Efficacy of HIV Combination Therapy
Trial Demonstrates Safety and Efficacy of HIV Combination Therapy
The 4-drug combination tablet (Symtuza) was approved by the FDA in July 2018 for infection of HIV type 1 (HIV-1) in treatment-naïve and certain virologically suppressed adults.
Read More >>
FDA Approves 2-Drug HIV Therapy for Previously Untreated Patients
Implantable Naltrexone May Improve Outcomes in Patients with HIV, Opioid Addiction
First-in-Human Clinical Trial Studying HIV Vaccine Candidate
Study: Older, Urban Men Most Likely to Achieve Medication Persistence with PrEP
CDC: Many New HIV Transmissions the Result of Those Unaware of Their Status
Study: Rate of Opioid-Related Deaths Increasing in Patients With HIV
Inserts Containing Combination Therapy May Protect Women Against HIV
View more articles >>
Clinical Trials
Plan and Pledge, HIV Self-testing in South Africa
Kenya HIV Self-Testing in PrEP Delivery
Diagnosis of HIV and Early Antiretroviral Therapy Initiation Among HIV-1 Infected Infants
Acceptability and Feasibility of Unsupervised HIV Self-Testing Among Networks of Men
Using Mobile Technology and Incentives With Men Who Have Sex With Men and Transgender Women for HIV Prevention
Multimedia: Videos
Pharmacists Play a Crucial Role in Helping Patients Manage HIV and Diabetes
Pharmacists Play a Crucial Role in Helping Patients Manage HIV and Diabetes
What Lifestyle Modifications Can Pharmacists Suggest to Patients Living with HIV and Diabetes?
What Lifestyle Modifications Can Pharmacists Suggest to Patients Living with HIV and Diabetes?
How Can Pharmacists Help Patients with HIV and Diabetes Manage Their Health?
How Can Pharmacists Help Patients with HIV and Diabetes Manage Their Health?
Common Coexisting Health Issues Seen in Patients with HIV
Common Coexisting Health Issues Seen in Patients with HIV